Ken Fisher
ALXN

Ken Fisher’s Alexion Pharmaceuticals ALXN Stock Holding History

Ken Fisher’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,001
Closed -$469K – 982
2020
Q4 		$469K Sell
3,001
-20,273
-87% -$2.61M ﹤0.01% 719
2020
Q3 		$2.66M Buy
23,274
+526
+2% +$56.7K ﹤0.01% 450
2020
Q2 		$2.55M Sell
22,748
-7,074
-24% -$751K ﹤0.01% 460
2020
Q1 		$2.68M Buy
29,822
+16,687
+127% +$1.64M ﹤0.01% 415
2019
Q4 		$1.42M Buy
13,135
+331
+3% +$35.4K ﹤0.01% 542
2019
Q3 		$1.25M Sell
12,804
-35
-0.3% -$3.94K ﹤0.01% 595
2019
Q2 		$1.68M Buy
+12,839
New +$1.65M ﹤0.01% 562

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ken Fisher's ALXN Position: Q1 2021 in Review

Ken Fisher sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 3,001 shares — an estimated $469K sold.

Ken Fisher first reported a position in ALXN in Q2 2019 and held it in 7 quarters. The position peaked at $2.68M in Q1 2020. 753 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Ken Fisher reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Ken Fisher sold 3,001 Alexion Pharmaceuticals shares in Q1 2021, an estimated $469K.
  • Ken Fisher first reported a position in Alexion Pharmaceuticals in Q2 2019 and held it in 7 quarters.
  • Ken Fisher's Alexion Pharmaceuticals position peaked at $2.68M in Q1 2020.
  • 753 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Fisher Asset Management's 13F filing for Q1 2021, filed 27 Apr 2021.